U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.3706G>C (p.Ala1236Pro) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 18, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003163050.2

Allele description [Variation Report for NM_000179.3(MSH6):c.3706G>C (p.Ala1236Pro)]

NM_000179.3(MSH6):c.3706G>C (p.Ala1236Pro)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.3706G>C (p.Ala1236Pro)
HGVS:
  • NC_000002.12:g.47806263G>C
  • NG_007111.1:g.28117G>C
  • NG_008397.1:g.104413C>G
  • NM_000179.3:c.3706G>CMANE SELECT
  • NM_001281492.2:c.3316G>C
  • NM_001281493.2:c.2800G>C
  • NM_001281494.2:c.2800G>C
  • NP_000170.1:p.Ala1236Pro
  • NP_000170.1:p.Ala1236Pro
  • NP_001268421.1:p.Ala1106Pro
  • NP_001268422.1:p.Ala934Pro
  • NP_001268423.1:p.Ala934Pro
  • LRG_219t1:c.3706G>C
  • LRG_219:g.28117G>C
  • LRG_219p1:p.Ala1236Pro
  • NC_000002.11:g.48033402G>C
  • NM_000179.2:c.3706G>C
Protein change:
A1106P
Links:
dbSNP: rs1553333039
NCBI 1000 Genomes Browser:
rs1553333039
Molecular consequence:
  • NM_000179.3:c.3706G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.3316G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.2800G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.2800G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003902066Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Nov 18, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Integrated analysis of unclassified variants in mismatch repair genes.

Pastrello C, Pin E, Marroni F, Bedin C, Fornasarig M, Tibiletti MG, Oliani C, Ponz de Leon M, Urso ED, Della Puppa L, Agostini M, Viel A.

Genet Med. 2011 Feb;13(2):115-24. doi: 10.1097/GIM.0b013e3182011489.

PubMed [citation]
PMID:
21239990

UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families.

Grandval P, Fabre AJ, Gaildrat P, Baert-Desurmont S, Buisine MP, Ferrari A, Wang Q, BĂ©roud C, Olschwang S.

Database (Oxford). 2013 May 31;2013:bat036. doi: 10.1093/database/bat036. Print 2013.

PubMed [citation]
PMID:
23729658
PMCID:
PMC3668602

Details of each submission

From Ambry Genetics, SCV003902066.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The p.A1236P variant (also known as c.3706G>C), located in coding exon 8 of the MSH6 gene, results from a G to C substitution at nucleotide position 3706. The alanine at codon 1236 is replaced by proline, an amino acid with highly similar properties. This variant has been identified in a proband who met Amsterdam II criteria for Lynch syndrome and tumor demonstrated high microsatellite instability with loss of MSH6 expression by immunohistochemistry (Pastrello C et al. Genet Med, 2011 Feb;13:115-24). In addition, this variant has been identified in at least one proband whose Lynch syndrome-associated tumor demonstrated loss of MSH6 expression by immunohistochemistry (Ambry internal data). However, this variant has also been identified in a proband whose late-onset Lynch syndrome-associated tumor demonstrated high microsatellite instability and loss of MLH1/PMS2 expression by immunohistochemistry (Grandval P et al. Database (Oxford), 2013 May;2013:bat036). Based on internal structural analysis, p.A1236P is moderately destabilizing to the local structure (Ambry internal data). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024